tetano
Editor, Senior Moderator
Pharmacol Res. 2020 Apr 10:104808. doi: 10.1016/j.phrs.2020.104808. [Epub ahead of print]
Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).
Abedi F[SUP]1[/SUP], Rezaee R[SUP]2[/SUP], Karimi G[SUP]3[/SUP].
Author information
PMID:32283223DOI:10.1016/j.phrs.2020.104808
Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).
Abedi F[SUP]1[/SUP], Rezaee R[SUP]2[/SUP], Karimi G[SUP]3[/SUP].
Author information
PMID:32283223DOI:10.1016/j.phrs.2020.104808